Literature DB >> 1276114

Early and late results of fascia lata transplantation in high myopia.

A P Nesterov, N B Libenson, A V Svirin.   

Abstract

Transplantation of a strip of fascia lata to strengthen the posterior sclera in high progressive myopia was performed on 184 eyes of 108 patients with myopia ranging from 7 to 39 D. Three weeks after surgery visual acuity with correction had improved by 0-1 to 0-5 in 151 eyes (82 per cent) and refractive power had decreased by 1 to 8 D in 169 eyes (92 per cent). In 105 eyes (67 patients) that were followed-up for periods of from 1 to 9 years myopia increased in six by 0-5 to 3 D. In 29 patients who had an operation on only one eye and were then followed-up for periods of from 1 to 7 years the degree of myopia in the fellow eye increased by 1-5 to 6 D in 24 (83 per cent), and of the eyes that were operated on myopia increased by 0-5 to 3 D in only 5 (17 per cent).

Entities:  

Mesh:

Year:  1976        PMID: 1276114      PMCID: PMC1017490          DOI: 10.1136/bjo.60.4.271

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  The use of autogenous fascia lata to correct lid and orbital deformities.

Authors:  J C Flanagan; C B Campbell
Journal:  Trans Am Ophthalmol Soc       Date:  1981

2.  The efficacy and safety of modified Snyder-Thompson posterior scleral reinforcement in extensive high myopia of Chinese children.

Authors:  Minjie Chen; Jinhui Dai; Renyuan Chu; Yifeng Qian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-02       Impact factor: 3.117

3.  Radial keratotomy: a comprehensive evaluation.

Authors:  A C Neumann; R H Osher; R E Fenzl
Journal:  Doc Ophthalmol       Date:  1984-01-30       Impact factor: 2.379

4.  Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect.

Authors:  Zequn Miao; Luojia Li; Xiaoli Meng; Lili Guo; Di Cao; Yanlei Jia; Dongmei He; Lvzhen Huang; Lejin Wang
Journal:  Biomed Res Int       Date:  2019-01-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.